Why is pre-exposure prophylaxis with hydroxychloroquine a safe and rationale approach against SARS-CoV-2 infection?

The potentiality of Hydroxychloroquine (HCQ) for pre-exposure prophylaxis against SARS-CoV-2 has not been explored in randomized controlled trials. However, there is rationale behind this potentiality in terms of demonstrated in-vitro effect of HCQ against SARS-CoV-2, safety profile of HCQ in health...

Descripción completa

Detalles Bibliográficos
Autores principales: Mehta, Sudhir, Bhandari, Sudhir, Mehta, Shaurya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Ltd on behalf of International Society for Antimicrobial Chemotherapy. 2020
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7836824/
https://www.ncbi.nlm.nih.gov/pubmed/32777441
http://dx.doi.org/10.1016/j.jgar.2020.07.022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7836824/
https://www.ncbi.nlm.nih.gov/pubmed/32777441
http://dx.doi.org/10.1016/j.jgar.2020.07.022

Ejemplares similares